Cargando…

Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease

Background: Pituitary stalk interruption syndrome (PSIS) is rare disease characterized by breech, hypoglycemia, micropenis/cryptorchidism at birth, short stature in childhood and later with delayed puberty. Aims: Single centre study to characterize- the clinical, biochemical and radiological feature...

Descripción completa

Detalles Bibliográficos
Autores principales: Diwaker, Chakra, Memon, Saba, Patil, Virendra, Lila, Anurag, Shah, Nalini, Bandgar, Tushar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067747/
http://dx.doi.org/10.4103/2230-8210.342199
_version_ 1784700074440261632
author Diwaker, Chakra
Memon, Saba
Patil, Virendra
Lila, Anurag
Shah, Nalini
Bandgar, Tushar
author_facet Diwaker, Chakra
Memon, Saba
Patil, Virendra
Lila, Anurag
Shah, Nalini
Bandgar, Tushar
author_sort Diwaker, Chakra
collection PubMed
description Background: Pituitary stalk interruption syndrome (PSIS) is rare disease characterized by breech, hypoglycemia, micropenis/cryptorchidism at birth, short stature in childhood and later with delayed puberty. Aims: Single centre study to characterize- the clinical, biochemical and radiological features, treatment and follow up of PSIS patients; phenotypic difference in patients with PSIS-Isolated GHD (IGHD) and PSIS-combined pituitary hormone deficiency (CPHD) by comparing with GHRHR, and POU1F1, PROP1 (combined) mutated cases respectively. Result: Of 56 PSIS (all sporadic; males-80%) cases, 36 were CPHD. Most common presentation was short stature (64.3%). Overall PSIS has higher breech presentation (36% vs. 6%) on comparing with genetically positive cases of IGHD/CPHD. Neonatal hypoglycemia was more frequent in CPHD (22% in both PSIS-CPHD and genetically positive CPHD) as compared to IGHD (0%:PSIS-IGHD and 1.9%:GHRHR-IGHD). Similarly, neonatal jaundice was more common in CPHD (42%:PSIS-CPHD and 22.2%:genetically positive CPHD) as compared to IGHD (5% in PSIS-IGHD and 1.9%:GHRHR-IGHD). Extra-pituitary malformation and skeletal anomalies were exclusively seen in PSIS cohort (CPHD>IGHD). Absent pituitary stalk and hyperprolactinemia was more frequent in PSIS-CPHD than PSIS-IGHD cohort. 75% IGHD and 83% CPHD males failed to achieve spontaneous puberty on follow up. Conclusion: Late presentation with short stature and delayed puberty is common. Breech presentation was higher in PSIS than other mutation positive cases. Radiological and skeletal abnormalities were only seen in PSIS cohort.
format Online
Article
Text
id pubmed-9067747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90677472022-05-05 Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease Diwaker, Chakra Memon, Saba Patil, Virendra Lila, Anurag Shah, Nalini Bandgar, Tushar Indian J Endocrinol Metab Abstracts … Esicon 2021 Background: Pituitary stalk interruption syndrome (PSIS) is rare disease characterized by breech, hypoglycemia, micropenis/cryptorchidism at birth, short stature in childhood and later with delayed puberty. Aims: Single centre study to characterize- the clinical, biochemical and radiological features, treatment and follow up of PSIS patients; phenotypic difference in patients with PSIS-Isolated GHD (IGHD) and PSIS-combined pituitary hormone deficiency (CPHD) by comparing with GHRHR, and POU1F1, PROP1 (combined) mutated cases respectively. Result: Of 56 PSIS (all sporadic; males-80%) cases, 36 were CPHD. Most common presentation was short stature (64.3%). Overall PSIS has higher breech presentation (36% vs. 6%) on comparing with genetically positive cases of IGHD/CPHD. Neonatal hypoglycemia was more frequent in CPHD (22% in both PSIS-CPHD and genetically positive CPHD) as compared to IGHD (0%:PSIS-IGHD and 1.9%:GHRHR-IGHD). Similarly, neonatal jaundice was more common in CPHD (42%:PSIS-CPHD and 22.2%:genetically positive CPHD) as compared to IGHD (5% in PSIS-IGHD and 1.9%:GHRHR-IGHD). Extra-pituitary malformation and skeletal anomalies were exclusively seen in PSIS cohort (CPHD>IGHD). Absent pituitary stalk and hyperprolactinemia was more frequent in PSIS-CPHD than PSIS-IGHD cohort. 75% IGHD and 83% CPHD males failed to achieve spontaneous puberty on follow up. Conclusion: Late presentation with short stature and delayed puberty is common. Breech presentation was higher in PSIS than other mutation positive cases. Radiological and skeletal abnormalities were only seen in PSIS cohort. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067747/ http://dx.doi.org/10.4103/2230-8210.342199 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Abstracts … Esicon 2021
Diwaker, Chakra
Memon, Saba
Patil, Virendra
Lila, Anurag
Shah, Nalini
Bandgar, Tushar
Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
title Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
title_full Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
title_fullStr Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
title_full_unstemmed Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
title_short Abstract 78: Pituitary stalk interruption syndrome (PSIS) is rare disease
title_sort abstract 78: pituitary stalk interruption syndrome (psis) is rare disease
topic Abstracts … Esicon 2021
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067747/
http://dx.doi.org/10.4103/2230-8210.342199
work_keys_str_mv AT diwakerchakra abstract78pituitarystalkinterruptionsyndromepsisisraredisease
AT memonsaba abstract78pituitarystalkinterruptionsyndromepsisisraredisease
AT patilvirendra abstract78pituitarystalkinterruptionsyndromepsisisraredisease
AT lilaanurag abstract78pituitarystalkinterruptionsyndromepsisisraredisease
AT shahnalini abstract78pituitarystalkinterruptionsyndromepsisisraredisease
AT bandgartushar abstract78pituitarystalkinterruptionsyndromepsisisraredisease